MVIS US Listed Pharmaceutical 25 Index

The modified market cap-weighted index tracks the performance of the largest and most liquid US-listed companies that derive at least 50% of their revenues from pharmaceuticals. The pure-play index contains only companies which are engaged primarily engaged in research (incl. research contractors) and development as well as production, marketing and sales of pharmaceuticals. Pharmacies are excluded. The MVIS US Listed Pharmaceutical 25 Index (MVPPH) has been licensed to underlie financial products with currently USD 157.99 million in assets under management.

Index Performance

Index performance of price, total return net and total return gross indices is displayed in realtime.

PeriodPriceTotal Return NetTotal Return Gross
Year-to-Date Performance3.74%5.12%5.45%
1-Year Performance-10.33%-8.83%-8.44%
3-Year Performance-6.04%-0.89%0.23%
5-Year Performance-6.28%2.60%4.53%
Since Inception (29 Sep 2000)80.03%160.17%111.88%

Index Records

Index highs and lows of price, total return net and total return gross indices are displayed in realtime.

PeriodPriceTotal Return NetTotal Return Gross
All Time High/Low2,325.90 / 551.16 3,118.07 / 560.95 2,500.60 / 976.33
52-Weeks High/Low2,032.28 / 1,651.54 2,890.82 / 2,355.48 2,344.74 / 1,912.16
Quarter High/Low1,889.59 / 1,738.60 2,723.50 / 2,511.43 2,216.78 / 2,045.12
Month High/Low1,829.49 / 1,738.60 2,638.43 / 2,511.43 2,148.09 / 2,045.12

Index Correlation and Volatility

Index correlation to selected index peers and index volatility are updated daily.

Index Correlation
MSCI ACWI Pharmaceuticals0.8325
DJ US Pharmaceuticals TSM0.8312
Index Volatility
22-day Volatility18.72
250-day Volatility16.55

Component Performance

Displayed are the best and worst index components over a selected period of time. Data is updated daily.

Best 5 Components1-YearYear-to-Date1-Day
ABBVIE INC-27.26%-23.69%1.70%
ASTRAZENECA PLC-SPONS ADR21.00%23.48%1.79%
BRISTOL-MYERS SQUIBB CO-17.83%-5.63%0.29%
GLAXOSMITHKLINE PLC-SPON ADR3.00%10.56%1.07%
JOHNSON & JOHNSON-0.22%3.30%0.71%
ELI LILLY & CO8.42%-2.06%0.41%
MERCK & CO. INC.29.13%15.27%1.47%
NOVARTIS AG-ADR24.13%21.23%1.17%
NOVO-NORDISK A/S-SPONS ADR7.18%14.41%1.05%
PFIZER INC-14.40%-17.96%0.75%
SANOFI-ADR3.61%2.34%1.41%
TEVA PHARMACEUTICAL-SP ADR-70.40%-51.69%6.28%
AMERISOURCEBERGEN CORP-0.04%17.69%0.02%
MCKESSON CORP13.75%33.44%1.18%
ZOETIS INC39.50%49.97%1.26%
PERRIGO CO PLC-34.38%24.75%1.68%
ENDO INTERNATIONAL PLC-80.96%-59.32%-1.66%
MALLINCKRODT PLC-87.18%-70.82%1.77%
MYLAN NV-50.74%-30.33%0.00%
JAZZ PHARMACEUTICALS PLC-23.06%7.98%-1.91%
GW PHARMACEUTICALS -ADR11.18%56.96%1.33%
PATTERSON COMPANIES INC-25.24%-9.83%-2.23%
CATALENT INC33.99%78.64%-0.13%
BAUSCH HEALTH COS INC0.13%21.28%5.36%
TAKEDA PHARM-ADR-17.45%-0.20%-1.55%
Worst 5 Components1-YearYear-to-Date1-Day
ABBVIE INC-27.26%-23.69%1.70%
ASTRAZENECA PLC-SPONS ADR21.00%23.48%1.79%
BRISTOL-MYERS SQUIBB CO-17.83%-5.63%0.29%
GLAXOSMITHKLINE PLC-SPON ADR3.00%10.56%1.07%
JOHNSON & JOHNSON-0.22%3.30%0.71%
ELI LILLY & CO8.42%-2.06%0.41%
MERCK & CO. INC.29.13%15.27%1.47%
NOVARTIS AG-ADR24.13%21.23%1.17%
NOVO-NORDISK A/S-SPONS ADR7.18%14.41%1.05%
PFIZER INC-14.40%-17.96%0.75%
SANOFI-ADR3.61%2.34%1.41%
TEVA PHARMACEUTICAL-SP ADR-70.40%-51.69%6.28%
AMERISOURCEBERGEN CORP-0.04%17.69%0.02%
MCKESSON CORP13.75%33.44%1.18%
ZOETIS INC39.50%49.97%1.26%
PERRIGO CO PLC-34.38%24.75%1.68%
ENDO INTERNATIONAL PLC-80.96%-59.32%-1.66%
MALLINCKRODT PLC-87.18%-70.82%1.77%
MYLAN NV-50.74%-30.33%0.00%
JAZZ PHARMACEUTICALS PLC-23.06%7.98%-1.91%
GW PHARMACEUTICALS -ADR11.18%56.96%1.33%
PATTERSON COMPANIES INC-25.24%-9.83%-2.23%
CATALENT INC33.99%78.64%-0.13%
BAUSCH HEALTH COS INC0.13%21.28%5.36%
TAKEDA PHARM-ADR-17.45%-0.20%-1.55%
Up